Table 2.

Glycemic control

	Fix group			Flex group			Group difference
	Baseline	Study	P	Baseline	Study	P	P
HbA1c
%	8.0 ± 2.1	6.8 ± 0.3	0.026	7.9 ± 1.5	6.6 ± 0.5	0.001	0.168
mmol/mol	64 ± 26.2	51 ± 3.3	0.026	63 ± 18.6	49 ± 5.5	0.001	0.168
Sensor glucose, mg/dL	174 ± 26	147 ± 23	0.002	168 ± 29	145 ± 18	0.005	0.804
CV, %	35.6 ± 8.1	34.1 ± 5.0	0.520	30.1 ± 4.4	30.8 ± 4.2	0.634	0.045
Sensor glucose values in range, %
<54 mg/dL	0.2 ± 0.4	0.1 ± 0.3	1.000	0.8 ± 1.4	0.5 ± 0.3	0.275	0.167
54–70 mg/dL	1.4 ± 0.5	1.5 ± 1.5	0.605	2.0 ± 1.5	2.7 ± 1.7	0.718	0.283
70–180 mg/dL	47.5 ± 18.3	73.5 ± 6.7	0.001	49.1 ± 16.8	80.3 ± 7.4	0.001	0.043
180–250 mg/dL	22.6 ± 8.1	19.0 ± 5.2	0.122	26.8 ± 8.2	13.5 ± 5.9	0.001	0.114
>250 mg/dL	28.3 ± 15.9	5.7 ± 3.6	0.001	21.3 ± 11.8	3.0 ± 2.4	0.001	0.012
TDD, units/kg/day	1.0 ± 0.6	1.1 ± 0.4	0.517	1.0 ± 0.6	1.1 ± 0.5	0.601	0.984
Basal insulin, % of TDD	43.2 ± 6.7	34.2 ± 7.1	0.001	44.8 ± 5.9	32.6 ± 5.2	0.001	0.459
Weight, kg	52.2 ± 12.7	53.5 ± 11.2	0.753	51.3 ± 10.7	52.4 ± 9.6	0.754	0.765

Data are mean ± SD. Study indicates 12 weeks of MiniMed 780G system use. CGM data at baseline were collected using the Guardian 4 sensor with the MiniMed 780G system for a 1-week period of training (no insulin delivery with pump).